HK1028961A1 - Compositions and methods for enhancing delivery of therapeutic agents to cells - Google Patents
Compositions and methods for enhancing delivery of therapeutic agents to cellsInfo
- Publication number
- HK1028961A1 HK1028961A1 HK00108262.4A HK00108262A HK1028961A1 HK 1028961 A1 HK1028961 A1 HK 1028961A1 HK 00108262 A HK00108262 A HK 00108262A HK 1028961 A1 HK1028961 A1 HK 1028961A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- cells
- methods
- therapeutic agents
- enhancing delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/889,355 US7002027B1 (en) | 1996-01-08 | 1997-07-08 | Compositions and methods for therapeutic use |
PCT/US1998/014241 WO1999002191A1 (en) | 1997-07-08 | 1998-07-08 | Compositions and methods for enhancing delivery of therapeutic agents to cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1028961A1 true HK1028961A1 (en) | 2001-03-16 |
Family
ID=25394956
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00108262.4A HK1028961A1 (en) | 1997-07-08 | 2000-12-21 | Compositions and methods for enhancing delivery of therapeutic agents to cells |
HK10101219.1A HK1134025A1 (en) | 1997-07-08 | 2010-02-04 | Compositions and kits for enhancing delivery of therapeutic agents to cells |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10101219.1A HK1134025A1 (en) | 1997-07-08 | 2010-02-04 | Compositions and kits for enhancing delivery of therapeutic agents to cells |
Country Status (21)
Country | Link |
---|---|
US (3) | US7002027B1 (da) |
EP (2) | EP1011733B1 (da) |
JP (2) | JP4460148B2 (da) |
KR (1) | KR100691572B1 (da) |
AR (1) | AR016312A1 (da) |
AT (2) | ATE434448T1 (da) |
AU (1) | AU774338B2 (da) |
CA (1) | CA2294709C (da) |
CY (1) | CY1109367T1 (da) |
DE (2) | DE69840932D1 (da) |
DK (1) | DK1011733T3 (da) |
ES (2) | ES2328094T3 (da) |
HK (2) | HK1028961A1 (da) |
HU (1) | HUP0002683A3 (da) |
IL (1) | IL133929A0 (da) |
MY (1) | MY138257A (da) |
NZ (1) | NZ502060A (da) |
PT (1) | PT1011733E (da) |
TW (1) | TW490306B (da) |
WO (1) | WO1999002191A1 (da) |
ZA (1) | ZA986003B (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040014709A1 (en) * | 1996-01-08 | 2004-01-22 | Canji, Inc. | Methods and compositions for interferon therapy |
US5789244A (en) * | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
US6392069B2 (en) * | 1996-01-08 | 2002-05-21 | Canji, Inc. | Compositions for enhancing delivery of nucleic acids to cells |
US7002027B1 (en) * | 1996-01-08 | 2006-02-21 | Canji, Inc. | Compositions and methods for therapeutic use |
US6583301B1 (en) | 1998-04-08 | 2003-06-24 | Celltech R & D Limited | Lipids |
AU2002366809A1 (en) * | 2001-12-20 | 2003-07-09 | Schering-Plough Corporation | Syn3 compositions and methods |
WO2004108088A2 (en) * | 2003-06-04 | 2004-12-16 | Canji, Inc. | Methods and compositions for interferon therapy |
NZ543970A (en) * | 2003-06-04 | 2008-09-26 | Canji Inc | Methods and compositions for interferon therapy |
US7790039B2 (en) * | 2003-11-24 | 2010-09-07 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for stem cell enrichment |
CN1893981B (zh) * | 2003-12-10 | 2011-03-23 | 坎基股份有限公司 | 用于治疗干扰素耐药性肿瘤的方法和组合物 |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US8716021B2 (en) * | 2005-09-07 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of replicators to prevent gene silencing |
EP2285369A2 (en) * | 2008-05-05 | 2011-02-23 | Tiltan Pharma Ltd | Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US20130079382A1 (en) | 2009-10-12 | 2013-03-28 | Larry J. Smith | Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro |
US20120147800A1 (en) * | 2010-12-10 | 2012-06-14 | Minyoung Park | Power management in a wireless network having stations with different power capabilities |
EP2675460A4 (en) | 2011-02-18 | 2014-07-09 | Kythera Biopharmaceuticals Inc | TREATMENT OF FAT TISSUE UNDER CHIN |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
US10492104B2 (en) * | 2016-03-10 | 2019-11-26 | Cable Television Laboratories, Inc. | Latency reduction in wireless service |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554386A (en) | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
US6207454B1 (en) * | 1989-10-16 | 2001-03-27 | Amgen Inc. | Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
US5120316A (en) * | 1990-09-28 | 1992-06-09 | Akzo N.V. | Urethral catheter and catheterization process |
WO1992006180A1 (en) | 1990-10-01 | 1992-04-16 | University Of Connecticut | Targeting viruses and cells for selective internalization by cells |
EP0489423B1 (de) * | 1990-12-06 | 1996-11-06 | Hoechst Aktiengesellschaft | Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindung als Arzneimittel |
DE69233725T2 (de) | 1991-06-28 | 2009-02-12 | The Regents Of The University Of Michigan, Ann Arbor | Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren |
JPH06509578A (ja) | 1991-07-26 | 1994-10-27 | ユニバーシティ・オブ・ロチェスター | 悪性細胞利用による癌治療法 |
US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
US5521291A (en) | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
US6013638A (en) * | 1991-10-02 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
US5795870A (en) * | 1991-12-13 | 1998-08-18 | Trustees Of Princeton University | Compositions and methods for cell transformation |
AU3434393A (en) | 1992-01-17 | 1993-08-03 | Regents Of The University Of Michigan, The | Targeted virus |
US5602023A (en) * | 1992-03-24 | 1997-02-11 | Csatary; Laszlo K. | Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same |
DK0636028T3 (da) | 1992-04-03 | 2004-07-12 | Univ California | Selvorganiserende polynucleotidleveringssystem omfattende et amfipatisk kationisk peptid |
EP0633943A4 (en) | 1992-04-03 | 1997-05-02 | Alexander T Young | GENTHERAPY USING TARGETED VIRAL VECTORS. |
US5334761A (en) | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
WO1994006923A1 (en) | 1992-09-24 | 1994-03-31 | The University Of Connecticut | Modification of a virus to redirect infectivity and enhance targeted delivery of polynucleotides to cells |
US5656609A (en) | 1992-09-24 | 1997-08-12 | University Of Connecticut | Method of enhancing and/or prolonging expression of gene introduced into a cell using colchicine |
US5346701A (en) | 1993-02-22 | 1994-09-13 | Theratech, Inc. | Transmucosal delivery of macromolecular drugs |
WO1995002698A1 (en) | 1993-07-12 | 1995-01-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
US5631236A (en) | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
US5804566A (en) * | 1993-08-26 | 1998-09-08 | The Regents Of The University Of California | Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
JPH07109983A (ja) * | 1993-10-13 | 1995-04-25 | Nippondenso Co Ltd | スクロール型圧縮機 |
ATE230260T1 (de) | 1993-10-15 | 2003-01-15 | Cytrx Corp | Therapeutische abgabesysteme und verfahren für ihre verwendung |
SK283703B6 (sk) | 1993-10-25 | 2003-12-02 | Canji, Inc. | Rekombinantný adenovírusový vektor a jeho použitie |
US6210939B1 (en) * | 1993-10-25 | 2001-04-03 | Canji, Inc. | Recombinant adenoviral vector and methods of use |
US5837533A (en) * | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
US5552309A (en) | 1994-09-30 | 1996-09-03 | Indiana University Foundation | Use of polyols for improving the introduction of genetic material into cells |
US7163925B1 (en) * | 1995-07-17 | 2007-01-16 | Board Of Regents, The University Of Texas System | p16 expression constructs and their application in cancer therapy |
WO1997005209A1 (en) * | 1995-07-28 | 1997-02-13 | Kohne David E | Method for enhancing chemiluminescence |
US7002027B1 (en) * | 1996-01-08 | 2006-02-21 | Canji, Inc. | Compositions and methods for therapeutic use |
US20040014709A1 (en) * | 1996-01-08 | 2004-01-22 | Canji, Inc. | Methods and compositions for interferon therapy |
US6392069B2 (en) * | 1996-01-08 | 2002-05-21 | Canji, Inc. | Compositions for enhancing delivery of nucleic acids to cells |
US5789244A (en) * | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
US5671110A (en) | 1996-01-23 | 1997-09-23 | Oneac Corporation | Ground skew protection method and apparatus |
US6283940B1 (en) * | 1997-08-29 | 2001-09-04 | S. Grant Mulholland | Catheter |
US6938069B1 (en) * | 2000-03-18 | 2005-08-30 | Computing Services Support Solutions | Electronic meeting center |
AU2002366809A1 (en) * | 2001-12-20 | 2003-07-09 | Schering-Plough Corporation | Syn3 compositions and methods |
KR100499787B1 (ko) * | 2002-11-29 | 2005-07-07 | 인티그런트 테크놀로지즈(주) | 스위치 모드 동작을 하는 선형성이 우수한 광대역 가변이득 증폭기 |
NZ543970A (en) * | 2003-06-04 | 2008-09-26 | Canji Inc | Methods and compositions for interferon therapy |
WO2004108898A2 (en) | 2003-06-04 | 2004-12-16 | Canji, Inc. | Transfection agents |
WO2004108088A2 (en) * | 2003-06-04 | 2004-12-16 | Canji, Inc. | Methods and compositions for interferon therapy |
CN1893981B (zh) | 2003-12-10 | 2011-03-23 | 坎基股份有限公司 | 用于治疗干扰素耐药性肿瘤的方法和组合物 |
-
1997
- 1997-07-08 US US08/889,355 patent/US7002027B1/en not_active Expired - Fee Related
-
1998
- 1998-07-07 ZA ZA986003A patent/ZA986003B/xx unknown
- 1998-07-07 MY MYPI98003070A patent/MY138257A/en unknown
- 1998-07-08 EP EP98934359A patent/EP1011733B1/en not_active Expired - Lifetime
- 1998-07-08 KR KR1020007000178A patent/KR100691572B1/ko not_active IP Right Cessation
- 1998-07-08 WO PCT/US1998/014241 patent/WO1999002191A1/en not_active Application Discontinuation
- 1998-07-08 IL IL13392998A patent/IL133929A0/xx unknown
- 1998-07-08 AT AT98934359T patent/ATE434448T1/de active
- 1998-07-08 CA CA2294709A patent/CA2294709C/en not_active Expired - Fee Related
- 1998-07-08 AU AU83901/98A patent/AU774338B2/en not_active Ceased
- 1998-07-08 NZ NZ502060A patent/NZ502060A/en not_active IP Right Cessation
- 1998-07-08 DE DE69840932T patent/DE69840932D1/de not_active Expired - Lifetime
- 1998-07-08 ES ES98934359T patent/ES2328094T3/es not_active Expired - Lifetime
- 1998-07-08 JP JP2000501781A patent/JP4460148B2/ja not_active Expired - Fee Related
- 1998-07-08 AT AT09008139T patent/ATE497786T1/de not_active IP Right Cessation
- 1998-07-08 AR ARP980103311A patent/AR016312A1/es unknown
- 1998-07-08 DK DK98934359T patent/DK1011733T3/da active
- 1998-07-08 PT PT98934359T patent/PT1011733E/pt unknown
- 1998-07-08 HU HU0002683A patent/HUP0002683A3/hu unknown
- 1998-07-08 ES ES09008139T patent/ES2362027T3/es not_active Expired - Lifetime
- 1998-07-08 EP EP09008139A patent/EP2106807B1/en not_active Expired - Lifetime
- 1998-07-08 DE DE69842133T patent/DE69842133D1/de not_active Expired - Lifetime
-
1999
- 1999-01-11 TW TW087111049A patent/TW490306B/zh not_active IP Right Cessation
-
2000
- 2000-12-21 HK HK00108262.4A patent/HK1028961A1/xx not_active IP Right Cessation
-
2006
- 2006-02-21 US US11/359,997 patent/US7538093B2/en not_active Expired - Fee Related
-
2009
- 2009-04-13 US US12/422,807 patent/US8022044B2/en not_active Expired - Fee Related
- 2009-09-15 CY CY20091100949T patent/CY1109367T1/el unknown
- 2009-12-24 JP JP2009293390A patent/JP2010070565A/ja not_active Withdrawn
-
2010
- 2010-02-04 HK HK10101219.1A patent/HK1134025A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1134025A1 (en) | Compositions and kits for enhancing delivery of therapeutic agents to cells | |
EP1005330A4 (en) | METHODS AND COMPOSITIONS FOR TARGETING COMPOUNDS TO MUSCLES | |
EP1165048A4 (en) | COMPOSITIONS AND METHOD FOR IMPROVED ADMINISTRATION OF IONIZABLE HYDROPHOLE THERAPEUTIC SUBSTANCES | |
HUP0104439A3 (en) | Pharmaceutical compositions for modulating responsiveness to corticosteroids and use thereof | |
EP1227821A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF | |
IL136488A0 (en) | Transdermal delivery of particulate vaccine compositions | |
ZA968907B (en) | Compositions and methods for buccal delivery of pharmaceutical agents | |
HUP0101017A3 (en) | Compositions and methods for systemic delivery of oral vaccines and therapeutic agents | |
EP0979225A4 (en) | CONNECTIONS AND PREPARATIONS FOR THE ADMINISTRATION OF ACTIVE AGENTS | |
HUP0004802A3 (en) | Nicotine compositions and methods of formulation thereof | |
EP1003523A4 (en) | COMPILATION AND TREATMENT METHOD OF LIVER TUMORS | |
AU6278298A (en) | Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents | |
IL133053A0 (en) | Local delivery of long lasting therapeutic agents | |
EP1119365A4 (en) | COMPOSITIONS AND METHODS FOR USING TUMOR CELLS | |
PL341058A1 (en) | Compositions useful in reducing weight of patient's body | |
GB2343117B (en) | Benzimidazole pharmaceutical composition and process of preparation | |
IL141936A0 (en) | Antibodies to c3b(1) for delivery of diagnostic and therapeutic agents to cancer cells | |
ZA983239B (en) | Stable active human ob protein compositions and methods | |
AU2193797A (en) | Delivery of therapeutic agents to the prostate | |
EP1009433A4 (en) | THERAPEUTIC COMPOSITION AND TREATMENT METHOD | |
HU9800623D0 (en) | Oral application of "(+)-o-demethyl-tramadol as analgesic active component | |
IL131355A0 (en) | Use of pivagabin to prepare pharmaceutical compositions | |
AU779514C (en) | Methods and compositions for use in gene therapy for treatment of hemophilia | |
GB9617346D0 (en) | Therapeutic methods and compositions for use therein | |
EP0850047A4 (en) | METHODS OF USE AND COMPOSITIONS OF THERAPEUTIC LIPID VESICLES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150708 |